[HTML][HTML] Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine

R Greco, M Francavilla, C Demartini… - The journal of headache …, 2023 - Springer
Cannabidiol (CBD) is the main pharmacologically active phytocannabinoid. CBD exerts an
analgesic effect in several pain models, does not have side effects and has low toxicity. The …

Chronic pain and cannabidiol in animal models: behavioral pharmacology and future perspectives

GK Silva-Cardoso, CRA Leite-Panissi - Cannabis and Cannabinoid …, 2023 - liebertpub.com
The incidence of chronic pain is around 8% in the general population, and its impact on
quality of life, mood, and sleep exceeds the burden of its causal pathology. Chronic pain is a …

[HTML][HTML] Cannabidiol for pain treatment: focus on pharmacology and mechanism of action

J Mlost, M Bryk, K Starowicz - International journal of molecular sciences, 2020 - mdpi.com
Cannabis has a long history of medical use. Although there are many cannabinoids present
in cannabis, Δ9tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) are the two …

A placebo‐controlled investigation of the analgesic effects, abuse liability, safety and tolerability of a range of oral cannabidiol doses in healthy humans

CA Arout, M Haney, ES Herrmann… - British journal of …, 2022 - Wiley Online Library
Aims Preclinical studies demonstrate that cannabidiol (CBD) elicits an antinociceptive
response in animal models of neuropathic pain; in humans, limited data are available to …

The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain

B Costa, AE Trovato, F Comelli, G Giagnoni… - European journal of …, 2007 - Elsevier
Cannabidiol, the major psycho-inactive component of cannabis, has substantial anti-
inflammatory and immunomodulatory effects. This study investigated its therapeutic potential …

[HTML][HTML] Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain

D De Gregorio, RJ McLaughlin, L Posa… - Pain, 2019 - journals.lww.com
Clinical studies indicate that cannabidiol (CBD), the primary nonaddictive component of
cannabis that interacts with the serotonin (5-HT) 1A receptor, may possess analgesic and …

Pain response to cannabidiol in induced acute nociceptive pain, allodynia, and hyperalgesia by using a model mimicking acute pain in healthy adults in a randomized …

T Schneider, L Zurbriggen, M Dieterle, E Mauermann… - Pain, 2022 - journals.lww.com
Preclinical studies have demonstrated the analgesic potential of cannabidiol (CBD). Those
suggesting an effect on pain-processing receptors have brought CBD back into focus. This …

[HTML][HTML] The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study

MAP Bloomfield, Y Yamamori, C Hindocha… - …, 2022 - Springer
Rationale There is growing interest in the therapeutic potential of cannabidiol (CBD) across
a range of psychiatric disorders. CBD has been found to reduce anxiety during …

Evaluating the antinociceptive efficacy of cannabidiol alone or in combination with morphine using the formalin test in male and female mice

DE Sepulveda, DP Morris… - Cannabis and …, 2022 - liebertpub.com
Introduction: Phytocannabinoids have emerged as a potential alternative treatment option
for individuals experiencing persistent pain. However, evidence-based research regarding …

Cannabidiol effectively reverses mechanical and thermal allodynia, hyperalgesia, and anxious behaviors in a neuropathic pain model: Possible role of CB1 and …

GK Silva-Cardoso, W Lazarini-Lopes, JE Hallak… - …, 2021 - Elsevier
The incidence of chronic pain is high in the general population and it is closely related to
anxiety disorders, which promote negative effects on the quality of life. The cannabinoid …